AGP Executive Report

Health System Resilience: A new study identifies staffing shortages and cyber threats as key risks for Luxembourg’s hospitals, recommending more local training and continued recruitment from abroad. Mental Health Care: Psychotherapy waiting lists can stretch to six months, while many therapists are not accepting new patients. More than 15,500 insured people used psychotherapy in 2024; talks on a CNS agreement remain stalled. Flu Season: Hospitals say they are prepared for new Covid and flu waves, and a nasal-spray flu vaccine is now available for children. Stem Cell Donation: A young father from Luxembourg donated stem cells to a seriously ill two-year-old in Germany, highlighting the value of joining the donor registry.

Mental Health Access: Luxembourg’s psychotherapy demand is outpacing supply, with waiting lists often at least six months and many therapists not taking new patients, even as CNS reimbursement rules still leave patients paying upfront. Health System Resilience: A new Luxembourg hospital federation study flags resource shortages and rising cybersecurity threats as key pressures on the country’s health system, urging continued recruitment from abroad and stronger local training. End-of-Life Care Debate: A roundtable says Luxembourg’s euthanasia law and palliative care remain full of grey areas, calling for clearer rules and noting political reluctance to update the framework. Medical Tech in Europe: Smith+Nephew launched its CARTIHEAL AGILI-C cartilage repair implant commercially in Europe, citing multi-year trial results for knee pain and function. Local Care & Community: Plooschter Projet reports a Luxembourg father’s stem-cell donation gave a critically ill toddler in Germany a second chance, renewing calls for more donors. Public Safety Incident: Police investigated a Bonnevoie neighbour dispute after allegations of threats and a neck-dragging incident; officers also handled a separate e-scooter case involving dangerous, modified riding. Infectious Disease Watch: Russia says no plague cases were found among contacts of a lab worker who died after pneumonia in Siberia, while ECDC reports no sign of sustained human-to-human spread.

Mental Health Access: Luxembourg’s psychotherapy demand is outpacing supply, with long waits (often at least six months) and many therapists not taking new patients, even as CNS reimbursement exists. Local Health System Resilience: A new Hospital Federation study flags resource shortages and growing cybersecurity threats as key risks to Luxembourg’s hospital resilience, urging continued recruitment from abroad and stronger training and career development. End-of-Life Care Debate: A roundtable says Luxembourg’s euthanasia law still leaves grey areas and palliative care is lacking, with calls for clearer rules and discussion of whether children and adolescents should be able to request euthanasia. Flu Season Preparedness: Hospitals in Luxembourg expect seasonal rises in flu and Covid, stressing annual flu vaccination for all age groups, including healthcare workers. New Treatment in Europe: Smith+Nephew’s CARTIHEAL AGILI-C cartilage repair implant is now commercially available in Europe, with 5-year trial results showing better knee outcomes than standard surgical care. Stem Cell Hope: A Luxembourg father donated stem cells after being matched through Plooschter Projet, giving a critically ill toddler a second chance. Workforce Learning: The Chamber of Employees reports growing demand for lifelong learning but criticises limited training opportunities at work, calling for more training leave days.

Flu & Covid Readiness: Luxembourg hospitals are seeing the usual autumn rise in flu and Covid cases, with staff and emergency rooms already preparing for seasonal surges; doctors stress annual flu vaccination for all age groups, including children and healthcare workers. Pediatric Vaccines: Luxembourg has rolled out the nasal spray flu vaccine “Fluenz” for children, offering a needle-free option (not for kids with very weak immune systems or certain egg allergies). Health System Resilience: A new study flags resource shortages and growing cybersecurity threats as key pressures on Luxembourg’s hospital resilience, urging continued recruitment from abroad plus better local training and career development. Mental Health Negotiations: Psychotherapists and the CNS remain in a slow-moving dispute over signing a convention, with reimbursements potentially shifting from negotiated agreements to regulation. End-of-Life Law Debate: A roundtable highlights gaps in Luxembourg’s euthanasia and palliative care framework, calling for clearer rules and noting political reluctance to modernise the law. Stem Cell Lifesaving: The Plooschter Projet reports a Luxembourg father’s stem cell donation giving a critically ill toddler in Germany a second chance. Local Health & Safety: Multiple road accidents and a fire in Mertzig prompted emergency responses across Luxembourg. Public Health & Skills: The Chamber of Employees says lifelong learning participation is rising but access to training leave and upskilling opportunities still need more support.

Flu & Covid readiness: Luxembourg hospitals say they’re braced for the seasonal rise, with doctors urging annual flu vaccination for all age groups, including healthcare workers, as colder weather and travel bring more Covid back. Health workforce pressure: A new Luxembourg hospital resilience study flags resource shortages and growing cybersecurity threats, alongside difficulty recruiting key roles; it calls for continued international hiring plus stronger local training and career development. Psychotherapy convention talks: Psychotherapists and the CNS remain in a slow-moving dispute as existing conventions near expiry, leaving reimbursements to be handled by regulation rather than a signed agreement. End-of-life law gaps: A roundtable highlights unresolved grey areas in Luxembourg’s euthanasia and palliative care framework, with calls for clearer rules and discussion of whether children and adolescents should be able to request euthanasia. Stem cell “second chance”: A young Luxembourg man’s stem cell donation helped save a critically ill toddler in Germany, with the story used to encourage more donors. Pediatric flu vaccine update: Luxembourg now offers the nasal spray Fluenz for children, aiming to broaden protection and reduce spread, with guidance for children who shouldn’t receive live vaccines. Research & innovation: CN Bio announced its 2026 Organ-on-a-chip e-Symposium, spotlighting human-relevant models to improve drug discovery decisions. Local environment affecting health: New forest surveys show severe tree decline linked to drought and pests, underscoring wider wellbeing risks from climate stress. Data security in health systems: Cyber threats are repeatedly cited as a growing vulnerability for Luxembourg’s hospital resilience, alongside staffing and resources.

Flu & Covid readiness: Luxembourg hospitals are seeing a predictable autumn rise in flu and Covid cases, with doctors urging annual flu vaccination for all age groups (including healthcare workers) and highlighting that colder weather and more travel are driving spread. New child flu vaccine: “Fluenz” nasal spray is now available for children in Luxembourg, offered free of charge via paediatricians/CHL or by prescription, with guidance that it’s not for kids with very weak immune systems or certain egg allergies. GLP-1 use in youth: New real-world research presented in Milan looks at how GLP-1 receptor agonist drugs are being prescribed for children and young people in Germany, Austria and Luxembourg, as use expands for obesity and type 2 diabetes. Forever chemicals in blood: A European Parliament-linked PFAS study includes Luxembourg participants, with reporting that Croatian participants found very high “forever chemical” levels—renewing pressure for monitoring and prevention. Local health & environment: Luxembourg’s forests are in steep decline, with surveys showing most trees damaged or under severe water stress, a climate-linked risk that can affect long-term wellbeing. Workforce learning: The Luxembourg Chamber of Employees calls for more resources for lifelong learning, citing limited training opportunities and asking to increase training leave days. Visa talks: Ghana has started discussions with Luxembourg and Benelux on a possible visa-waiver arrangement, alongside cooperation on digital tech and agro-processing.

Seasonal respiratory health: Luxembourg hospitals are seeing a predictable autumn rise in both flu and Covid cases, with staff and patients affected too; doctors stress flu vaccination for all age groups and note that colder weather and more travel indoors can fuel spread. Vaccines for kids: Luxembourg has started offering the nasal flu spray “Fluenz” for children, with guidance that it’s not for very weak immune systems or certain egg allergies, and it’s free via paediatricians/CHL or prescription. Education & health workforce readiness: The Luxembourg Chamber of Employees says lifelong learning participation is growing, but access is still too limited, calling for more training leave days and more employer support. Medical access in Europe: The EU Court of Justice backed a Luxembourg student denied entry to Belgian medical studies under a residency-based quota, ruling it amounted to indirect discrimination. Diabetes treatment in Luxembourg: New EASD research looks at real-world use of GLP-1 drugs in children and young people across Germany, Austria and Luxembourg, where approvals cover both type 2 diabetes and weight management. Environment & health link: Luxembourg forests are in steep decline, with surveys showing most trees damaged or under severe water stress as droughts, heatwaves and pests intensify.

Flu & Covid readiness: Luxembourg hospitals are seeing a predictable autumn rise in flu and Covid cases, with emergency rooms, staff and patients all affected; doctors stress annual flu vaccination for all age groups and note that colder weather and returning travellers are boosting spread. Child flu vaccine update: “Fluenz” nasal spray is now available for children in Luxembourg, with guidance that it’s a live vaccine and not for kids with very weak immune systems or certain egg allergies. Lifelong learning pressure: The Luxembourg Chamber of Employees says demand for upskilling is growing, but access is shrinking inside companies; it calls for more resources and more training leave days, arguing the current 80-day career allowance isn’t enough. EU return rules: Luxembourg backed the EU Return Regulation, paving the way for “return hubs” outside the EU and expanded detention powers. Diabetes drug use in youth: New research at EASD looks at real-world GLP-1 use in children and young people across Germany, Austria and Luxembourg.

Seasonal Respiratory Watch: Luxembourg hospitals are bracing for the usual autumn rise in flu and Covid, with staff and patients seeing more cases in emergency departments; doctors stress yearly flu vaccination for all age groups and note travel returning to the country can bring Covid back. Lifelong Learning Push: The Luxembourg Chamber of Employees says participation in training is growing, but access is still too limited—calling for more resources and more training leave days as upskilling opportunities inside companies keep shrinking. Kids’ Flu Protection: Luxembourg has expanded flu prevention with the nasal spray vaccine “Fluenz” for children, offered free of charge via paediatricians/CHL and with guidance for children who shouldn’t receive live vaccines. EU Return Rules: Luxembourg-backed EU legislation clears final adoption of new return rules, including “return hubs” outside the EU and expanded detention powers, with parts applying immediately and most rules starting a year later. Diabetes & Weight-Meds in Youth: New real-world research presented for Germany, Austria and Luxembourg looks at how GLP-1 drugs are actually used in children and young people with obesity and type 2 diabetes. Medical Innovation in Luxembourg: EIB recognition goes to PRECISIS for targeted neuromodulation therapy for drug-resistant focal epilepsy, highlighting a path from tech to clinical practice.

Pediatric Flu Protection: Luxembourg has started offering the live nasal flu vaccine “Fluenz” for children, with guidance that it’s not for kids with very weak immune systems or certain egg allergies, and it’s available via paediatricians/CHL or prescription. Diabetes & Weight-Loss Drugs in Youth: New real-world research presented for Germany, Austria and Luxembourg looks at how GLP-1 receptor agonists are being used in children and young people, after EU approvals expanded indications for type 2 diabetes and obesity. Neuromodulation Breakthrough: EIB has selected Luxembourg-based PRECISIS for an Innovation Champion Award for its targeted, reversible neurostimulation therapy for drug-resistant focal epilepsy (EASEE). Pharma Growth Watch: Santhera reports 101% revenue growth for the first half of 2026, driven by expanding AGAMREE access and commercial momentum across markets. Healthcare Access & Costs (EU/Global): The EU has cleared new return rules that expand detention powers and enable “return hubs” outside the bloc—an indirect but important policy backdrop for health and welfare planning. Local Health System Context: Luxembourg’s Superior Council flagged legal-basis risks in draft rules tied to the National Health Fund (CNS) and AMMD convention, including prescription validity and sick-note limits.

Pediatric Flu Protection: Luxembourg has rolled out the nasal spray flu vaccine “Fluenz” for children, offering a needle-free option at paediatricians or CHL, with free access and clear cautions for kids with very weak immune systems or certain egg allergies. EU Migration & Returns: EU home affairs ministers backed new return rules, including “return hubs” outside the bloc, stronger detention powers, and a common European return order—rules that Luxembourg helped finalize. Local Health Policy Legal Check: Luxembourg’s Council of State flagged legality risks in draft Grand Ducal regulations replacing the CNS–AMMD convention, pointing to missing legal bases for prescription validity, sick-note limits, and fee restrictions. Diabetes Drug Use in Youth: New EASD research looks at real-world prescribing of GLP-1 receptor agonists for children and young people in Germany, Austria, and Luxembourg, as use expands beyond earlier approvals. Neurotechnology in Luxembourg: EIB recognized PRECISIS with an Innovation Champion Award for targeted neuromodulation therapy for drug-resistant focal epilepsy. Child Neurodevelopment Care Abroad: A donation from Solidaridad Luxemburgo-Cuba will expand comprehensive care for children with autism and other neurodevelopmental disorders in Cuba’s Holguín province.

Euthanasia Debate: Netherlands confirmed the assisted euthanasia of a 1-year-old with severe cerebral palsy and epilepsy, the youngest case since child euthanasia was allowed—reviewed by the national termination committee and with no planned prosecution. Child Health & Development: Luxembourg’s speech therapy centre (CL) links rising reading and language difficulties to early-life habits, urging more shared play and less smartphone distraction; nearly 3,000 children are now treated, with diagnoses up sharply since 2017/18. Diabetes Drugs in Youth: New EASD research looks at real-world use of GLP-1 receptor agonists in children and teens in Germany, Austria and Luxembourg, where approvals cover type 2 diabetes and obesity/weight management. Healthcare Regulation Watch (Luxembourg): The Council of State flagged legality risks in draft Grand Ducal rules replacing the CNS–AMMD convention, saying prescription validity, sick-note limits and fee restrictions need a clear legal basis in the Social Security Code. EU Border Health Checks: EU rules under the Migration and Asylum Pact include identity, security, health and vulnerability checks for irregular arrivals, alongside expanding digital border controls. Neurotechnology in Epilepsy: EIB-backed PRECISIS received an Innovation Champion Award for EASEE, a targeted reversible neurostimulation therapy for drug-resistant focal epilepsy.

Child Development & Screen Time: Luxembourg’s speech therapy centre (CL) says early language difficulties are rising fast, with nearly 3,000 children now treated—nearly double since 2018/19—and it links the trend to less real interaction at home, urging more shared play and less constant smartphone distraction. Diabetes Drugs in Youth: New EASD research looks at real-world use of GLP-1 receptor agonists in children and young people across Germany, Austria and Luxembourg, where approvals cover type 2 diabetes from age 10 and obesity from age 12 (now also down to age 6). Healthcare Rules in Luxembourg: The Council of State flagged legality risks in draft Grand Ducal regulations meant to replace the CNS–AMMD convention, warning that prescription validity, sick-note limits and fee restrictions need a clear legal basis in the Social Security Code. Neuromodulation Innovation: EIB-backed PRECISIS is set to receive the EIB Innovation Champion Award in Luxembourg for its targeted, reversible neurostimulation therapy for drug-resistant focal epilepsy. EU Health & Trade: The EU Court of Justice refused Poland’s bid to suspend provisional application of the EU–Mercosur interim trade deal, rejecting claims of serious and irreparable harm to health, the environment or farmers. Safe Abortion Statement: EU and UK governments and ambassadors reaffirmed support for safe, timely and affordable abortion care on International Safe Abortion Day, citing WHO guidance that restrictive laws increase harm. Workforce Burnout Watch: A Europe-wide junior doctors survey reports heavy workloads (57 hours/week on average) and widespread dissatisfaction, with work-life balance flagged as a key driver of burnout.

EU Health & Courts: Luxembourg’s Council of State flagged legality risks in two draft Grand Ducal regulations meant to replace the National Health Fund (CNS) and AMMD convention, warning key rules (like prescription validity, sick-note limits, and fee restrictions) need a clear legal basis in the Social Security Code. Medical Innovation in Luxembourg: The EIB Innovation Champion Award went to PRECISIS in Luxembourg for its targeted neuromodulation therapy EASEE for drug-resistant focal epilepsy, supported by a €20m EIB venture loan. Spine Tech Clearance: Xenix Medical announced FDA 510(k) clearance for NanoACTIV Surface Technology on its Riva modular pedicle screw system, extending osteogenic surface tech to more implant types. Global Health Care Access: Solidaridad Luxembourg-Cuba funded expanded multidisciplinary care for children and teens with autism and other neurodevelopmental disorders in Cuba’s Holguín province. Animal Health Costs: A proposed merger between Covetrus and MWI Animal Health is drawing FTC scrutiny over potential impacts on veterinary product pricing and practice software. Policy & Migration (Health-adjacent): The EU is tightening border security and migration controls under the Migration and Asylum Pact, including identity, security, health and vulnerability checks.

CNS/AMMD Legal Overhaul: Luxembourg’s Council of State flagged legality risks in draft Grand Ducal regulations meant to replace the National Health Fund (CNS) and doctors’ convention (AMMD), warning that prescription validity, sick-note limits and fee restrictions need a clear legal basis in the Social Security Code. Public Health Access: On International Safe Abortion Day, Luxembourg joined a group of EU governments and diplomats calling for laws and policies that support safe, timely and affordable abortion care, citing WHO findings that restrictive laws increase maternal harm. Medical Innovation in Focus: Santhera Pharmaceuticals reported progress for AGAMREE® in Europe and beyond, highlighting expanding pricing/reimbursement and patient access. EU Courtroom Watch: Alphabet/Google filed appeals in Luxembourg’s General Court against EU Digital Markets Act orders requiring search-data sharing and Android access for AI rivals, arguing privacy and security could be harmed. Workforce & Health System Pressure: A Europe-wide junior doctors survey reports heavy workloads (57 hours/week on average) and poor work-life balance, linking dissatisfaction to burnout and dropout risk. Local Health Context: Luxembourg’s unemployment rose to 6.5%, while temporary job offers increased—demand noted in logistics, retail, healthcare and construction.

Digital Health & Privacy: Alphabet/Google has filed appeals in Luxembourg’s EU General Court against EU Digital Markets Act orders that would (from Jan 2027) require sharing anonymized Google Search data with AI and rival search providers, and (by mid-2027) open Android access for competing AI assistants—Google warns this could expose highly personal queries (including medical worries) and weaken Android security. Healthcare Workforce Burnout: A Europe-wide Junior Doctors survey reports many trainees are dissatisfied, with work-life balance flagged as a major driver of burnout and dropouts; respondents average about 57 hours a week. Local Health Governance: Luxembourg’s Council of State raises legal concerns over draft regulations replacing the CNS–AMMD convention, saying key rules (like prescription validity, limits on sick notes, and bans on charging before services) need a clearer legal basis in the Social Security Code. Workplace Safety: Eurostat data shows fatal workplace accident rates vary widely across EU countries; Luxembourg is among the lowest, while France’s reporting system may inflate comparisons. Safe Abortion Access: Luxembourg is among governments signing an International Safe Abortion Day statement urging laws and policies that support safe, timely, affordable abortion care and decriminalisation.